ArticleBMC biology2026
Rhobot-Screen: an integrated robotic platform for functional screening of rhodopsin variants.
Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundRhodopsins are photoreceptive membrane proteins widely used as optogenetic tools in basic research and medical applications, and extensive mutational studies have been performed to improve or modify their functional properties. Recently, in the broader field of protein engineering, data-driven strategies based on machine learning have attracted increasing attention, as they enable efficient exploration of vast mutational spaces with a reduced number of experiments. Such approaches require large, consistent datasets that link predefined mutations to quantitative functional properties, which necessitates systematic construction and characterization of targeted variants rather than random mutagenesis. For rhodopsins, however, generating these datasets remains challenging due to operator-dependent, non-integrated workflows that are difficult to scale and standardize.
resultsTo address this limitation, we developed an automated screening platform termed Rhobot-Screen, based on a robotic liquid-handling workstation, which integrates multiple experimental steps into a standardized workflow with reduced dependence on operator-specific expertise. This platform performs site-directed mutagenesis, plasmid preparation, protein expression in bacterial and mammalian cultured cells, and functional characterization in a 96-well format through automated liquid-handling operations. For spectroscopic characterization, we established a 96-well plate-based hydroxylamine bleaching assay that determines absorption maximum wavelengths without protein purification. As a demonstration of the platform, we comprehensively mutated three established color-tuning residues in Gloeobacter rhodopsin, generating 57 single-point variants. Using Rhobot-Screen, the absorption maxima of 46 variants were successfully determined. The resulting dataset revealed position-dependent relationships between spectral shifts and amino acid physicochemical properties, with clear correlations between absorption wavelength and side-chain volume at positions 129 and 256, but not at position 226. The platform was further extended to mammalian cell-based assays for functional characterization of animal rhodopsins.
conclusionsRhobot-Screen provides an integrated workflow in which all liquid-handling steps for systematic construction and spectroscopic characterization of rhodopsin variants are automated in a 96-well plate format under standardized conditions. By automating and standardizing multiple operator-dependent steps, the platform provides a reproducible framework for acquiring quantitative sequence-function data from predefined rhodopsin variants. This framework should support both mechanistic studies of rhodopsins and future data-driven engineering of rhodopsin functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.